NCT06129656Recruiting
Cardiac Amyloidosis Registry of University Hospital Leipzig
Source: ClinicalTrials.gov · Last updated 13 Nov 2023 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
This is a clinical registry of patients with cardiac amyloidosis being treated at University Hospital Leipzig. The aim of the registry is to collect detailed information about clinical events, symptoms, imaging, biomarkers, comorbidities, and treatment from routine patient management which would not be provided by randomized clinical trails.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 500 (estimated)
- First submitted
- 19 Oct 2023
- Start date
- 1 May 2023
- Primary completion date
- 31 May 2033
- Lead sponsor
- University of Leipzig
- Diseases
- Amyloidosis, Heart failure
- NCT number
- NCT06129656
What you commit to
- Study type: Observational
- Planned participants: 500
- From 1 May 2023 to the primary completion date, 31 May 2033
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- refusal to participate
Who the study is looking for
- Confirmed cardiac amyloidosis according to current standards
Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University Hospital Leipzig Coordinator of this site? Confirm its status | Leipzig | Germany | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.